Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Chief Scientific Officer sold 114,240 shares at $16.25 ($1,856,263)
  7. 4 Open-market sale Chief Operating Officer sold 26,649 shares at an average $15.46 ($412,065)
  8. 4 Open-market sale Chief Operating Officer sold 2,488 shares at $17.45 ($43,418)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Financial Officer sold 7,402 shares at $21.55 ($159,513)
  12. 4 Open-market sale Chief Financial Officer sold 46,144 shares at an average $19.95 ($920,736)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Operating Officer sold 2,500 shares at $17.94 ($44,852)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 20 · 399 filings